Prevention and Risk-Based Surveillance Key to Curbing HCCOctober 9, 2025Hepatocellular CarcinomaLiver DiseaseGI Oncology
Journal Highlights: January-April 2025June 18, 2025Upper GI TractIBD & Intestinal DisordersPancreas and Biliary TractLiver DiseaseEndoscopyHepatocellular CarcinomaGI Oncology
Bringing HCC Patients Hope Through Trials, Advanced TreatmentsMay 1, 2025Hepatocellular CarcinomaLiver DiseaseGI Oncology
Infrequent HDV Testing Raises Concern for Worse Liver OutcomesApril 7, 2025Liver DiseaseHepatocellular Carcinoma
Could Statins Prevent Hepatocellular Carcinoma?April 4, 2025GI OncologyLiver DiseaseHepatocellular Carcinoma
New Risk Score Might Improve HCC Surveillance Among Cirrhosis PatientsFebruary 7, 2025Liver DiseaseHepatocellular Carcinoma
New Model Estimates Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis BJanuary 17, 2025Liver DiseaseGI OncologyHepatocellular Carcinoma
Lipophilic Statins May Protect Against HCC In Select Liver Disease PatientsJanuary 9, 2025Liver DiseaseHepatocellular CarcinomaGI Oncology
Some Antihypertensives Linked to HCC Risk in Patients With MASLD and CirrhosisDecember 16, 2024Liver DiseaseHepatocellular Carcinoma
Fewer than 1 out of 4 patients with HCV-related liver cancer receive antiviralsDecember 4, 2023Liver DiseaseHepatocellular Carcinoma
More than one-third of adults in the US could have NAFLD by 2050December 4, 2023Liver DiseaseHepatocellular Carcinoma
Drug combo improves recurrence-free survival after HCC resectionApril 27, 2023Hepatocellular Carcinoma
Commentary: Combination therapies and immunotherapy in HCC, December 2022November 29, 2022Hepatocellular Carcinoma
